◎文/陳柏瑋
檢驗項目參考值:
BUN (blood urea nitrogen): 7-20 mg/dL; SCr (serumcreatinine): male:
0.7-1.5 mg/dL; female: 0.5-1.2 mg/dL;CCr (Creatinine clearance
rate): >60 mL/min; ALT (alanineaminotransferase): 0-40 U/L; AST (aspartate
aminotransferase):5-45 U/L;K: 3.5-5.0 mEq/L
參考資料:
1. Repatha [dosing and titration guide]. West Greenwich, USA: Amgen
Manufacturing; 2017.
2. Praluent [dosing and titration guide]. Le Trait, France: Sanofi
Winthrop Industrie; 2019.
3. Po-Sheng Chen, Meng Lee, Sung-Chun Tang, et al. 2022 focused
update of the 2017 Taiwan lipid
guidelines for high risk patients: Coronary artery disease,
peripheral artery disease and ischemic stroke. J Formos Med Assoc.
2022;121:1363-70.
(全文完)
(本文作者為臺北榮民總醫院藥學部臨床藥師 /陽明大學藥理所碩士)
回首頁 |